ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

SURVEY: Cognitive Impairment II

Top 3 Nutrients to Detox the Liver and Soothe Digestion

Natural Bladder Control, Go Less and Live More

Study bodes well for low-carb eaters

Top Vitamin and Mineral Deficiencies — Are You at Risk?

Vital Molecule Increases Cellular Energy and Improves Cognitive Function

Omega Fix for Obesity: How the Right Fats Fight Fat

Potential of Quercetin in the Treatment of Melanoma

How Pomegranate May Protect Against Cancer

Trimming the spare tire: Canola oil may cut belly fat

 
Print Page
Email Article

Discovery Helps Determine Which Breast Cancer Tumors are Most Likely to Spread

  [ 157 votes ]   [ Discuss This Article ]
www.ProHealth.com • November 18, 2002


A new molecular tag discovered by scientists at The University of Texas M. D. Anderson Cancer Center may help doctors to predict which breast cancer tumors are more likely to metastasize and spread, thereby helping to decide which patients need more aggressive treatment and which can forego the potentially toxic course of chemotherapy.

Khandan Keyomarsi, Ph.D., associate professor in experimental radiation at M. D. Anderson, conducted a study with tissue samples of current or former breast cancer patients, and found that high levels of a protein called cyclin E are closely associated with aggressive, invasive breast cancer, and is a much better predictor of patient outcome than any current predictive marker.

The ability to predict which breast cancer tumors will recur or spread throughout the body is an important aspect of breast cancer treatment, said Keyomarsi. Currently, the prognosis for women diagnosed with breast cancer is determined by whether tumor cells have spread to lymph nodes. However some women who have cancer cells in the lymph nodes never have a recurrence, while others whose cancer has not spread do have a recurrence. Yet many women, after discussions with their doctors, opt to undergo grueling chemotherapy in hopes of ensuring any rogue cancer cells that may be present are killed. If an accurate predictive marker were available, many women could be spared chemotherapy, she said.

Cyclin E is present at high levels inside cancer cells and constantly signals them to multiply. In normal cells, cyclin E is present only for a short time and helps keep cell division under tight control. Keyomarsi discovered smaller versions of cyclin E that are not present in normal cells. These low molecular weight versions are generated by an enzyme that chops up the normal cyclin E and in the process creates a new form that is even better at signaling cells to divide.

"We have shown the occurrence of low molecular weight forms of cyclin E that are not found in normal cells and are present throughout cell cycle in cancer cells," said Keyomarsi. "These abnormal forms of cyclin E are always giving the 'go' signal, telling cells to divide."

The study examined tumor tissue from 395 patients with breast cancer. Of those patients with stage one breast cancer, in which a single tumor is found and the cancer has not yet spread, about 10 percent had high levels of cyclin E in their cancer cells. All of these patients had died from a recurrence of breast cancer within five years of diagnosis, while none of the patients who had low levels of cyclin E had died. The proportion of tumors that had high levels of cyclin E increased with increasing extent of disease.

However, said Keyomarsi, the study must be repeated with newly diagnosed patients to determine its true predictive value.

"This study shows that the presence of low molecular weight forms of cyclin E has a very powerful prognostic value," said Keyomarsi. "However, we have to validate the study using newly diagnosed patients in which we are blinded to the diagnosis. We are in the midst of that study now. If it bears out our initial results, we will try to get it into the clinic as soon as possible, though it may be at least one year."

For those patients who have high levels of cyclin E more aggressive treatment would be indicated, she said. And intensive research is now underway at M. D. Anderson to find ways to stop production or block cyclin E in those patients where it is present.



Post a Comment

Featured Products From the ProHealth Store
Energy NADH™ 12.5mg Ultra EPA  - Fish Oil FibroSleep™


Article Comments



Be the first to comment on this article!

Post a Comment


 
Natural Pain Relief Supplements

Featured Products

FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function

Natural Remedies

Coenzyme Q10 - The Energy Maker Coenzyme Q10 - The Energy Maker
Coconut Oil - Healthy Gifts from the 'Tree of Life' Coconut Oil - Healthy Gifts from the 'Tree of Life'
Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients Cell-Charging Compound Gives Steady Energy to Fibromyalgia & Chronic Fatigue Patients
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS
Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera Soothe, Heal and Regulate Your Digestive System with Nutrient-Rich Aloe Vera

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map